Filing Flows

Filing Flows › Omeros (OMER) › Stock forecast & fair value

Omeros (OMER) stock forecast and fair value

Omeros (OMER) trades at $20.03. 2 analysts' median price target is $27.50 (+37%), from $22.00 to $33.00. Across 10 valuation methods the middle fair value is $19.26 (-4%).

Price$20.03
Median target$27.50
Fair value, middle$19.26
EPS beat rate100%
Omeros fair value by method (price $20.03)Omeros fair value by method (price $20.03)low – highpoint estimateP/E vs peers$27.47P/E vs peers, weighted$44.97P/E vs peers, growth-adjusted$41.96Analysts' price targets$27.50Owner earnings capitalized$19.26Tangible book (asset value)$0.00Net cash (floor)$0.65Stage-weighted value (pre-revenue)$0.41Graham formula (revised)$8.37Lynch fair P/E (PEGY)$6.96

Fair value by method

MethodLowPointHighvs price
P/E vs peers$18.26$27.47$60.35+37%
P/E vs peers, weighted$25.11$44.97$66.46+125%
P/E vs peers, growth-adjusted$24.47$41.96$71.96+109%
Analysts' price targets$22.00$27.50$33.00+37%
Owner earnings capitalized$16.99$19.26$22.24-4%
Tangible book (asset value)$0.00$0.00$0.00—
Net cash (floor)$0.59$0.65$0.65-97%
Stage-weighted value (pre-revenue)$0.37$0.41$0.41-98%
Graham formula (revised)$8.37$8.37$14.28-58%
Lynch fair P/E (PEGY)$6.96$6.96$6.96-65%

Omeros' latest quarter

Omeros, Q2 2026: revenue $28.5M, operating margin 0.3%, net earnings $13.2M, operating cash flow $4.1M. The chart follows the revenue to costs, profit and cash.

Questions

What is the price target for OMER stock?

The median of 2 analysts' 12-month targets is $27.50, +37% from $20.03; the range is $22.00 to $33.00. The average rating is none.

What is Omeros' fair value?

The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $44.97, with a middle value of $19.26 against a price of $20.03. Each method's assumptions are on the page.

Does Omeros usually beat earnings estimates?

It beat the consensus EPS estimate in 100% of the quarters on record.

Is OMER stock a buy?

Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.